Clinical aspects of medication overuse headaches

Headache

Volumn 54, Issue 1, 2014, Pages 211-217

  Da Silva, Arnaldo Neves ^a   Lake III, Alvin E ^a  

^a Michigan Head Pain and Neurological Institute   (United States)

Author keywords

analgesic; chronic daily headache; medication overuse headache

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; CAFFEINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRIPTAN DERIVATIVE;

CHRONIC DAILY HEADACHE; CLINICAL FEATURE; COGNITIVE THERAPY; COMPLEX MEDICATION OVERUSE HEADACHE; DISTRESS SYNDROME; DRUG DEPENDENCE; DRUG INDUCED HEADACHE; HUMAN; INCIDENCE; INSOMNIA; MENTAL DISEASE; MIGRAINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REMISSION; REVIEW; SIMPLE MEDICATION OVERUSE HEADACHE; SLEEP DISORDER;

ANALGESIC; CHRONIC DAILY HEADACHE; MEDICATION OVERUSE HEADACHE;

ANALGESICS; BARBITURATES; HEADACHE DISORDERS, SECONDARY; HUMANS; TRYPTAMINES;

EID: 84892372875     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12223     Document Type: Review

References (67)

1. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-746.
2. De Felice M, Ossipov MH, Porreca F,. Update on medication-overuse headache. Curr Pain Headache Rep. 2011; 15: 79-83.
3. Tepper SJ,. Medication-overuse headache. Continuum (Minneapolis Minn). 2012; 18: 807-822.
4. Castillo J, Munoz P, Guitera V, Pascual J,. Kaplan award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999; 39: 190-196.
5. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB,. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008; 48: 1157-1168.
6. Lipton RB,. Tracing transformation: Chronic migraine classification, progression, and epidemiology. Neurology. 2009; 72 (Suppl. 5): S3-S7.
7. Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME,. Frequent headaches in the preadolescent pediatric population: A population-based study. Neurology. 2010; 74: 903-908.
8. Ghiotto N, Sances G, Galli F, et al. Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia. 2009; 29: 233-243.
9. Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany-The German DMKG headache study. Cephalalgia. 2010; 30: 207-213.
10. Colas R, Munoz P, Temprano R, Gomez C, Pascual J,. Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life. Neurology. 2004; 62: 1338-1342.
11. Evers S, Marziniak M,. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010; 9: 391-401.
12. Wang SJ, Fuh JL, Lu SR, Juang KD,. Chronic daily headache in adolescents: Prevalence, impact, and medication overuse. Neurology. 2006; 66: 193-197.
13. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: Data from a physician survey. Headache. 1996; 36: 14-19.
14. Russell MB, Lundqvist C,. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012; 25: 290-295.
15. Piazza F, Chiappedi M, Maffioletti E, Galli F, Balottin U,. Medication overuse headache in school-aged children: More common than expected? Headache. 2012; 52: 1506-1510.
16. Ferrari A, Leone S, Vergoni AV, et al. Similarities and differences between chronic migraine and episodic migraine. Headache. 2007; 47: 65-72.
17. Wiendels NJ, van Haestregt A, Knuistingh Neven A, et al. Chronic frequent headache in the general population: Comorbidity and quality of life. Cephalalgia. 2006; 26: 1443-1450.
18. Bigal ME, Lipton RB,. Excessive acute migraine medication use and migraine progression. Neurology. 2008; 71: 1821-1828.
19. Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB,. Opioid use and dependence among persons with migraine: Results of the AMPP study. Headache. 2012; 52: 18-36.
20. Diener HC, Dahlof CGH,. Headache associated with chronic use of substances. In:, Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 2nd edn. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999: 671-878.
21. Dodick DW, Silberstein SD,. How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia. 2008; 28: 1207-1217.
22. Katsarava Z, Jensen R,. Medication-overuse headache: Where are we now? Curr Opin Neurol. 2007; 20: 326-330.
23. Evers S, Bauer B, Suhr B,. Ergotamine-induced headache associated with cluster headache. Neurology. 1996; 46: 291.
24. Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ,. Medication-overuse headache in patients with cluster headache. Neurology. 2006; 67: 109-113.
25. Johnson JL, Hutchinson MR, Williams DB, Rolan P,. Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment. Cephalalgia. 2013; 33: 52-64.
26. Meng ID, Dodick D, Ossipov MH, Porreca F,. Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies. Cephalalgia. 2011; 31: 851-860.
27. De Felice M, Ossipov MH, Wang R, et al. Triptan-induced latent sensitization: A possible basis for medication overuse headache. Ann Neurol. 2010; 67: 325-337.
28. Supornsilpchai W, le Grand SM, Srikiatkhachorn A,. Cortical hyperexcitability and mechanism of medication-overuse headache. Cephalalgia. 2010; 30: 1101-1109.
29. Riederer F, Marti M, Luechinger R, et al. Grey matter changes associated with medication-overuse headache: Correlations with disease related disability and anxiety. World J Biol Psychiatry. 2012; 13: 517-525.
30. Onaya T, Ishii M, Katoh H, et al. Predictive index for the onset of medication overuse headache in migraine patients. Neurol Sci. 2013; 34: 85-92.
31. Radat F, Lanteri-Minet M,. Addictive behaviour in medication overuse headache: A review of recent data. Rev Neurol (Paris). 2011; 167: 568-578.
32. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J,. Analgesic use: A predictor of chronic pain and medication overuse headache: The head-HUNT study. Neurology. 2003; 61: 160-164.
33. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC,. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002; 59: 1011-1014.
34. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V,. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001; 57: 1694-1698.
35. Katsarava Z, Diener HC, Limmroth V,. Medication overuse headache: A focus on analgesics, ergot alkaloids and triptans. Drug Saf. 2001; 24: 921-927.
36. Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA,. Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trondelag Health Studies. Pain. 2012; 153: 56-61.
37. Bahra A, Walsh M, Menon S, Goadsby PJ,. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003; 43: 179-190.
38. Wilkinson SM, Becker WJ, Heine JA,. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache. 2001; 41: 303-309.
39. Waeber C, Moskowitz MA,. Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology. 2003; 61 (8 Suppl. 4): S9-20.
40. Calabresi P, Cupini LM,. Medication-overuse headache: Similarities with drug addiction. Trends Pharmacol Sci. 2005; 26: 62-68.
41. Tepper SJ, Tepper DE,. Breaking the cycle of medication overuse headache. Cleve Clin J Med. 2010; 77: 236-242.
42. Silberstein SD, Lipton RB, Sliwinski M,. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology. 1996; 47: 871-875.
43. Diener HC, Dodick DW, Aurora SK, et al. PREEMPT 2 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010; 30: 804-814.
44. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ,; TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia. 2007; 27: 814-823.
45. Creac'h C, Radat F, Mick G, et al. One or several types of triptan overuse headaches? Headache. 2009; 49: 519-528.
46. Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P,. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A. 2011; 108: 9262-9267.
47. Saper JR, Hamel RL, Lake AE 3rd,. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia. 2005; 25: 545-546.
48. Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M,. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain. 2005; 9: 285-291.
49. Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache. 2009; 49: 1005-1013.
50. Sullivan MD, Edlund MJ, Steffick D, Unutzer J,. Regular use of prescribed opioids: Association with common psychiatric disorders. Pain. 2005; 119: 95-103.
51. Fuh JL, Wang SJ, Lu SR, Juang KD,. Does medication overuse headache represent a behavior of dependence? Pain. 2005; 119: 49-55.
52. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-5, 5th edn. American Psychiatric Association; 2013.
53. Radat F, Lanteri-Minet M,. What is the role of dependence-related behavior in medication-overuse headache? Headache. 2010; 50: 1597-1611.
54. Ferraro S, Grazzi L, Muffatti R, et al. In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas. Headache. 2012; 52: 1520-1534.
55. Lake AE 3rd, Saper JR, Hamel RL,. Comprehensive inpatient treatment of refractory chronic daily headache. Headache. 2009; 49: 555-562.
56. Rothrock J, Lopez I, Zweilfer R, Andress-Rothrock D, Drinkard R, Walters N,. Borderline personality disorder and migraine. Headache. 2007; 47: 22-26.
57. Saper JR, Lake AE 3rd,. Medication overuse headache: Type I and type II. Cephalalgia. 2006; 26: 1262.
58. Lake AE 3rd,. Screening and behavioral management: Medication overuse headache-The complex case. Headache. 2008; 48: 26-31.
59. Lake AE 3rd,. Medication overuse headache: Biobehavioral issues and solutions. Headache. 2006; 46 (Suppl. 3): S88-S97.
60. Fuh JL, Wang SJ,. Dependent behavior in patients with medication-overuse headache. Curr Pain Headache Rep. 2012; 16: 73-79.
61. Rossi P, Faroni JV, Nappi G,. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2011; 18: 396-401.
62. Manack A, Buse DC, Serrano D, Turkel CC, Lipton RB,. Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology. 2011; 22: 711-718.
63. Scher AI, Stewart WF, Ricci JA, Lipton RB,. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003; 106: 81-89.
64. Grazzi L, Andrasik F, D'Amico D, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: Outcome at 3 years. Headache. 2002; 42: 483-490.
65. Hagen K, Jensen R, Boe MG, Stovner LJ,. Medication overuse headache: A critical review of end points in recent follow-up studies. J Headache Pain. 2010; 11: 373-377.
66. Hagen K, Albretsen C, Vilming ST, et al. A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. J Headache Pain. 2011; 12: 315-322.
67. Diener HC,. Detoxification for medication overuse headache is not necessary. Cephalalgia. 2012; 32: 423-427.